Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.

David, D; Bani, L; Moreau, J L; Treilhou, M P; Nakarai, T; Joussemet, M; Ritz, J; Dupont, B; Pialoux, G; Thèze, J

David, D; Bani, L; Moreau, J L; Treilhou, M P; Nakarai, T; Joussemet, M; Ritz, J; Dupont, B; Pialoux, G; Thèze, J.

Affiliation

David D; Unité d'Immunogénétique Cellulaire, Département d'Immunologie, Institut Pasteur, Paris, France.

Proc Natl Acad Sci U S A ; 95(19): 11348-53, 1998 Sep 15.

Article in En | MEDLINE | ID: mdl-9736739

Subject(s)

HIV Infections/drug therapy; Receptors, Interleukin-2/metabolism; B-Lymphocytes/drug effects; B-Lymphocytes/virology; CD4-Positive T-Lymphocytes/drug effects; CD4-Positive T-Lymphocytes/virology; CD8-Positive T-Lymphocytes/drug effects; CD8-Positive T-Lymphocytes/virology; Cell Count/drug effects; Cell Cycle/physiology; Flow Cytometry; Gene Expression Regulation/drug effects; HIV Protease Inhibitors/pharmacology; Humans; Immunity, Cellular/immunology; Interleukin-2/metabolism; Killer Cells, Natural/drug effects; Reverse Transcriptase Inhibitors/pharmacology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Receptors, Interleukin-2 / HIV Infections Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 1998 Document type: Article

Fulltext

XML

PubMed Links

Search on Google